Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

56results about How to "Highly specific detection" patented technology

Kit for detecting colorectal cancer and precancerous lesions and use method thereof

PendingCN109097471AReduce the rate of missed diagnosis and missed detectionSampling is convenientMicrobiological testing/measurementBiological testingKRAS Gene MutationSulfite
The invention relates to a kit for detecting colorectal cancer and precancerous lesions and a use method thereof. The invention provides the kit for detecting colorectal cancer and precancerous lesions, and the kit comprises a nucleic acid separation and purification reagent, a DNA sulfite conversion reagent, a KRAS gene mutation detection reagent, an SDC2 and SFRP2 gene methylation detection reagent and a fecal occult blood detection reagent, wherein the nucleic acid separation and purification reagent is used for separating and purifying human DNA in a fecal sample; and the DNA sulfite conversion reagent is used for converting the partial purified human DNA into sulfite for subsequent detection of the methylation level of SDC2 and SFRP2 genes. The sensitivity of the kit for detecting thecolorectal cancer can reach up to 90% or more and the specificity is about 85%, thereby realizing high-sensitivity and high-specificity detection of the colorectal cancer; and the kit provided by theinvention can detect most precancerous lesions of the colorectal cancer to realize ultra-early detection of the colorectal cancer, and can greatly reduce missed diagnosis and missed detection rates of clinical existing methods when being used for assisting clinical diagnosis.
Owner:HANGZHOU HEYI GENE TECH

DNA nano-molecule machine for exosome and surface protein analysis and application

The invention relates to a DNA nano-molecule machine for exosome and surface protein analysis and application. The DNA nano-molecule machine comprises an identification probe generating response to asurface marker of an exosome, a signal probe containing two Toehold regions and a fuel probe capable of driving cycling of a strand displacement reaction. The exosome is subjected to polyvalent conjugation with a specific aptamer in the identification probe through the surface marker of the exosome, so as to release an initiating strand in the identification probe; the initiating strand invades the signal probe and drives branches of the strand to migrate and release a quenching strand through being conjugated with a Toehold region I, a fluorescence reporter group is liberated, and a concealedToehold region II is exposed; and the fuel probe starts up a Toehold-mediated strand displacement cyclic reaction through being conjugated with the Toehold region II, and continuous branch migrationand polyvalent recovery occur. Supersensitive quantitative detection on the exosome can be achieved; bi-color or multicolor analysis on two or more kinds of protein markers on the surface of the exosome can be achieved; and the operation is simple, the consumed time is short, the sample consumption is low, the sensitivity is high, and the specificity is good.
Owner:HUBEI UNIV OF CHINESE MEDICINE

Fluorescence method for detecting brain natriuretic peptide based on graphene oxide/nucleic acid aptamer

The invention provides a homogeneous fluorescence detection novel method of brain natriuretic peptide (BNP) with high sensitivity, high selectivity and low cost. The method comprises the following steps of through constructing a graphene oxide / fluorescent dye-labeled nucleic acid aptamer composite probe, using a fluorescence quenching effect of the graphene oxide to the dye to reduce a detected fluorescent background signal; when BNP is added and a nucleic acid aptamer make the fluorescent dye be far away from the graphene oxide through a specific molecular recognition effect, recovering a fluorescence signal of the dye, and establishing a linear working curve based on changes of BNP concentration and fluorescence intensity; and finally, through testing a fluorescence intensity change value after the sample is added and substituting into the working curve, calculating and acquiring accurate concentration of the BNP in a clinical sample. Various immunoassays have cross reaction due to usage of antibody recognition. By using the method of the invention, the above disadvantage is overcome; interferences of related peptides and the like are avoided; the method has advantages of simpleness, speediness, low cost, high sensitivity, high selectivity and the like; and the method can be used for quantitative detection of the BNP in blood of patients in clinical application, and can be used for timely diagnosis, treatment guidance and prognosis prompting.
Owner:CHONGQING MEDICAL UNIVERSITY

Aptamer probe for detecting two kinds of tumor makers and electrochemical biosensor and preparation method and application thereof

The invention discloses an aptamer probe for detecting two kinds of tumor makers and an electrochemical biosensor and a preparation method and application thereof. The aptamer probe comprises an aptamer sequence, the aptamer sequence and the tumor marker I are subjected to specific recognition and closely bound, the 5' end and the 3' end of the aptamer probe are subjected to complementary hybridization to make the aptamer probe form a hairpin structure, and the stem portion of the hairpin structure comprises a recognition sequence of the tumor maker II and a recognition site of restriction enzyme. The electrochemical biosensor is prepared by fixing the aptamer probe on the surface of a working electrode. By means of the aptamer probe for detecting the two kinds of tumor makers and the electrochemical biosensor and the preparation method and application thereof, parallel analysis of multiple kinds of tumor marker molecules of thrombin and M.Sss I DNA methylation transferase can be achieved; the biosensor is high in detection sensibility, the lower detection limit for the thrombin is 0.1 ng / mL, and the lower detection limit for the M.Sss I DNA methylation transferase is 0.04 U / mL.
Owner:GUANGZHOU YUEWANG AGRI CO LTD

Preparation method of photoelectrochemical sensor for detecting in-situ ratio of Cry1Ab protein in transgenic crop

The invention belongs to the technical field of biosensors, and discloses a preparation method of an in-situ ratio photoelectrochemical immunosensor which is applied to detection of Cry1Ab protein in transgenic crops. Au NRs and MB are used as double sensitizers to realize double amplification of PEC signals. On the one hand, Au NRs modified CdTe QDs with an SPR effect is used as a photoelectric layer, so that initial signal amplification is realized; on the other hand, MB serving as a PEC signal enhancer is embedded into dsDNA, and secondary signal amplification is achieved. The concentration of Cry1Ab is quantitatively detected by taking the light current after the target object is added and the light current generated by the Ab2-CdSe QDs-dsDNA sensitized by the MB as a specific value respectively. The two signals are acquired at the same electrode and are mutually referenced, so that the interference of a solution matrix and environmental factors on the electrode is effectively reduced. The detection range of the photoelectrochemical sensor is 0.01-100 ng.mL <-1 >, and the detection limit is as low as 1.4 pg.mL <-1 >. The in-situ ratio PEC sensor constructed by the invention has good stability, selectivity and reproducibility, and realizes sensitive detection of Cry1Ab protein in transgenic crops.
Owner:JIANGSU UNIV

Biological probe and detection method for detecting miRNA and application

The invention belongs to the technical field of biosensors and relates to a biological probe and detection method for detecting miRNA and application. The biological probe comprises a first arch probebody and a second arch probe body; the first arch probe body and the second arch probe body are both formed by complementary hybridization of terminal bases of two single-stranded linear molecules; the first arched probe body comprises a target miRNA binding sequence region, an endonuclease recognition sequence region and a DNA polymerase extension sequence region; oligonucleotide which is released through chain extension and a shear reaction of the first arch probe body and the target miRNA after binding is adopted as a secondary primer; the second arch probe body comprises a secondary primer binding sequence region, an endonuclease recognition sequence region and a DNA polymerase extension report sequence region; the second arch probe body is bonded with the secondary primer and then subjected to chain extension and a shear reaction to release a report sequence. The miRNA detection method based on mediation of the biological probe of the miRNA has the advantages of being high in sensitivity and specificity, simple in design, rapid in detection and low in cost.
Owner:JIANGSU INST OF NUCLEAR MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products